Index RUT
P/E 42.32
EPS (ttm) 3.23
Insider Own 2.59%
Shs Outstand 33.33M
Perf Week 8.15%
Market Cap 4.66B
Forward P/E 22.54
EPS next Y 6.07
Insider Trans -4.32%
Shs Float 32.67M
Perf Month 6.65%
Income 113.55M
PEG 1.97
EPS next Q 1.46
Inst Own 112.15%
Short Float 8.07%
Perf Quarter 18.50%
Sales 1.70B
P/S 2.75
EPS this Y 14.25%
Inst Trans 5.61%
Short Ratio 10.03
Perf Half Y 20.00%
Book/sh 48.33
P/B 2.83
EPS next Y 13.71%
ROA 3.81%
Short Interest 2.64M
Perf Year 59.25%
Cash/sh 1.04
P/C 131.05
EPS next 5Y 21.53%
ROE 7.42%
52W Range 83.69 - 136.07
Perf YTD 38.03%
Dividend Est. -
P/FCF 62.79
EPS past 5Y -
ROI 4.09%
52W High 0.51%
Beta 1.10
Dividend TTM -
Quick Ratio 2.09
Sales past 5Y 6.27%
Gross Margin 25.44%
52W Low 63.41%
ATR (14) 3.65
Dividend Ex-Date -
Current Ratio 3.28
EPS Y/Y TTM 38.45%
Oper. Margin 13.07%
RSI (14) 64.86
Volatility 2.51% 2.71%
Employees 10500
Debt/Eq 0.72
Sales Y/Y TTM 8.80%
Profit Margin 6.70%
Recom 1.40
Target Price 140.88
Option/Short Yes / Yes
LT Debt/Eq 0.71
EPS Q/Q 22.70%
Payout 0.00%
Rel Volume 0.75
Prev Close 134.58
Sales Surprise -2.08%
EPS Surprise 5.03%
Sales Q/Q 5.95%
Earnings Oct 24 BMO
Avg Volume 262.81K
Price 136.76
SMA20 5.65%
SMA50 6.49%
SMA200 15.44%
Trades
Volume 196,445
Change 1.62%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-16-24 Initiated
Oppenheimer
Outperform
$135
May-15-24 Initiated
Truist
Buy
$137
Apr-15-24 Upgrade
BofA Securities
Neutral → Buy
$105 → $135
Mar-14-24 Initiated
CL King
Buy
$137
Feb-06-24 Resumed
KeyBanc Capital Markets
Overweight
$125
May-26-23 Initiated
Wells Fargo
Equal Weight
$87
May-11-23 Initiated
Citigroup
Neutral
$88
Mar-30-23 Initiated
BofA Securities
Neutral
$86
Feb-24-23 Initiated
Piper Sandler
Overweight
$85
Jun-09-21 Upgrade
Argus
Hold → Buy
$100
Oct-07-20 Downgrade
Argus
Buy → Hold
May-14-20 Initiated
The Benchmark Company
Buy
$105
Jul-06-18 Reiterated
KeyBanc Capital Mkts
Overweight
$65 → $78
Jun-27-18 Initiated
Argus
Buy
$78
Oct-23-17 Downgrade
Northcoast
Buy → Neutral
Show Previous Ratings
Nov-01-24 07:00AM
07:00AM
Oct-29-24 09:45AM
Oct-25-24 08:29AM
05:57AM
(Thomson Reuters StreetEvents)
03:11AM
Loading…
03:11AM
Oct-24-24 08:15AM
(Associated Press Finance)
08:00AM
08:00AM
Oct-23-24 09:05AM
Oct-09-24 12:21PM
Oct-02-24 04:05PM
06:00AM
Sep-30-24 08:00AM
08:00AM
08:00AM
Loading…
Sep-26-24 08:00AM
Sep-23-24 08:00AM
Sep-20-24 09:40AM
Sep-18-24 09:45AM
Sep-10-24 09:50AM
Sep-04-24 09:40AM
Sep-02-24 09:45AM
Aug-23-24 08:18AM
Aug-22-24 08:00AM
Aug-16-24 01:23PM
Aug-01-24 07:02PM
09:50AM
08:00AM
Jul-31-24 09:45AM
Jul-29-24 09:40AM
12:54PM
Loading…
Jul-26-24 12:54PM
Jul-25-24 08:13AM
(Associated Press Finance) -7.12%
08:00AM
07:00AM
(Investor's Business Daily)
Jul-01-24 04:05PM
Jun-28-24 09:40AM
Jun-27-24 04:00PM
Jun-12-24 11:51AM
Jun-06-24 07:01PM
04:00PM
May-24-24 12:38PM
May-15-24 06:14AM
May-14-24 04:22PM
May-13-24 11:22AM
May-09-24 04:48PM
May-07-24 08:00AM
May-01-24 08:00AM
Apr-30-24 09:06AM
Apr-26-24 01:07PM
Apr-25-24 11:42PM
(Thomson Reuters StreetEvents) -9.83%
12:53PM
10:00AM
09:32AM
09:15AM
08:00AM
Apr-18-24 10:01AM
Apr-16-24 09:15AM
Apr-13-24 12:18PM
Apr-10-24 01:31PM
Apr-09-24 11:47AM
Mar-28-24 08:00AM
Mar-25-24 09:45AM
Mar-14-24 09:40AM
Mar-12-24 08:00AM
Mar-08-24 08:21AM
Feb-27-24 09:40AM
Feb-16-24 10:53AM
09:19AM
Feb-15-24 11:27PM
(Thomson Reuters StreetEvents)
08:42AM
08:12AM
(Associated Press Finance)
08:00AM
Feb-12-24 09:15AM
Feb-07-24 09:40AM
Feb-01-24 08:00AM
Jan-23-24 09:50AM
Jan-22-24 09:40AM
Jan-17-24 09:15AM
Jan-16-24 08:00AM
06:18AM
Jan-15-24 10:33AM
Jan-11-24 09:21AM
Jan-10-24 04:15PM
Jan-03-24 09:40AM
08:00AM
Dec-29-23 09:15AM
Dec-21-23 07:42AM
Dec-15-23 09:40AM
Dec-13-23 10:57AM
09:15AM
Nov-24-23 09:40AM
Nov-20-23 10:41AM
Nov-16-23 08:00AM
Nov-08-23 08:00AM
Nov-03-23 12:27PM
12:22PM
09:40AM
09:35AM
09:34AM
09:34AM
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. It operates through the Medical and Non-Medical segments. The Medical segment includes the cardio and vascular, cardiac and neuromodulation, surgical, orthopedics, and portable medical product lines. The Non-Medical segment comprises customized battery power and management systems, charging and docking stations, and power supplies. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Hobby Jean M. Director Jul 31 '24 Option Exercise 42.29 11,385 481,508 18,265 Aug 01 04:55 PM Hobby Jean M. Director Jul 31 '24 Sale 119.66 11,960 1,431,132 2,280 Aug 01 04:55 PM MAXWELL MARTIN C Director Jul 31 '24 Sale 118.88 4,700 558,724 20,656 Aug 01 04:42 PM Harris John A EVP, Global Ops and Manufactur Jul 30 '24 Sale 123.80 3,400 420,920 1,522 Aug 01 04:38 PM Hobby Jean M. Director Jul 31 '24 Proposed Sale 119.66 11,960 1,431,132 Jul 31 01:16 PM MAXWELL MARTIN C Director Jul 31 '24 Proposed Sale 119.15 4,700 560,000 Jul 31 12:50 PM Harris John A Officer Jul 30 '24 Proposed Sale 123.80 3,400 420,920 Jul 30 02:34 PM Harris John A EVP, Global Ops and Manufactur Jun 04 '24 Sale 120.44 1,521 183,182 4,922 Jun 06 04:05 PM Hinrichs James F. Director May 24 '24 Option Exercise 44.60 9,603 428,294 17,027 May 28 03:20 PM Hinrichs James F. Director May 24 '24 Sale 122.44 9,603 1,175,772 7,424 May 28 03:20 PM Khales Payman President, C&V May 10 '24 Sale 113.84 8,712 991,739 10,431 May 14 04:08 PM Harris John A EVP, Global Ops and Manufactur May 07 '24 Sale 113.00 312 35,256 1,157 May 09 04:13 PM Senn Andrew SVP, Strategy and Business Dev May 07 '24 Sale 113.14 5,000 565,708 4,658 May 09 04:12 PM Thomas Tommy P VP, Corporate Controller Apr 30 '24 Sale 114.00 1,500 171,000 2,813 May 02 04:08 PM BAILEY PAMELA G Director Jan 02 '24 Option Exercise 40.86 1,722 70,361 51,266 Jan 03 04:26 PM Dziedzic Joseph W President & CEO Jan 02 '24 Option Exercise 40.86 1,722 70,361 159,535 Jan 03 04:24 PM
Index RUT
P/E -
EPS (ttm) -3.14
Insider Own 3.49%
Shs Outstand 37.16M
Perf Week 14.45%
Market Cap 790.19M
Forward P/E -
EPS next Y -0.91
Insider Trans 0.00%
Shs Float 36.88M
Perf Month 29.40%
Income -119.03M
PEG -
EPS next Q -0.27
Inst Own 94.54%
Short Float 6.91%
Perf Quarter 21.01%
Sales 784.25M
P/S 1.01
EPS this Y 31.88%
Inst Trans -0.54%
Short Ratio 11.00
Perf Half Y 32.58%
Book/sh 13.76
P/B 1.41
EPS next Y 67.67%
ROA -13.42%
Short Interest 2.55M
Perf Year 63.66%
Cash/sh 0.80
P/C 24.28
EPS next 5Y 9.40%
ROE -20.86%
52W Range 9.57 - 19.47
Perf YTD 43.99%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -17.73%
52W High -0.31%
Beta 1.06
Dividend TTM -
Quick Ratio 1.11
Sales past 5Y 13.08%
Gross Margin 65.83%
52W Low 102.72%
ATR (14) 0.72
Dividend Ex-Date -
Current Ratio 2.39
EPS Y/Y TTM 19.53%
Oper. Margin -10.91%
RSI (14) 79.11
Volatility 5.58% 3.83%
Employees 1634
Debt/Eq 0.30
Sales Y/Y TTM 17.32%
Profit Margin -15.18%
Recom 1.80
Target Price 24.40
Option/Short Yes / Yes
LT Debt/Eq 0.28
EPS Q/Q 8.15%
Payout -
Rel Volume 2.91
Prev Close 18.22
Sales Surprise 0.04%
EPS Surprise -105.80%
Sales Q/Q 6.85%
Earnings Nov 07 BMO
Avg Volume 231.49K
Price 19.41
SMA20 16.79%
SMA50 19.54%
SMA200 30.72%
Trades
Volume 673,214
Change 6.53%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-08-24 Upgrade
Stifel
Hold → Buy
$18 → $24
May-08-24 Upgrade
ROTH MKM
Neutral → Buy
$15 → $20
Oct-20-23 Initiated
ROTH MKM
Neutral
$12
Sep-12-23 Downgrade
Stifel
Buy → Hold
Sep-12-23 Downgrade
BTIG Research
Buy → Neutral
Jul-19-23 Resumed
BTIG Research
Buy
$27
Mar-04-22 Upgrade
Stifel
Hold → Buy
$41 → $45
Oct-20-20 Initiated
Stifel
Hold
$39
Oct-29-19 Downgrade
Cantor Fitzgerald
Overweight → Neutral
$71 → $48
Jun-01-18 Initiated
Cantor Fitzgerald
Overweight
Jun-21-17 Initiated
BTIG Research
Buy
$52
Jun-14-17 Initiated
Ladenburg Thalmann
Buy
$53.25
May-23-17 Initiated
SunTrust
Buy
$49
Jul-10-15 Initiated
Sidoti
Buy
May-09-13 Downgrade
Mizuho
Buy → Neutral
$45 → $28
Jan-08-13 Reiterated
Mizuho
Buy
$47 → $45
Jun-21-10 Initiated
Boenning & Scattergood
Outperform
$45
Mar-09-10 Reiterated
Jefferies & Co
Buy
$38 → $40
Feb-18-10 Upgrade
Susquehanna Financial
Neutral → Positive
Jan-22-10 Initiated
Jefferies & Co
Buy
$37
Show Previous Ratings
Nov-08-24 07:32AM
02:14AM
Nov-07-24 08:25AM
07:23AM
(Associated Press Finance)
07:05AM
07:05AM
Loading…
07:05AM
Nov-06-24 07:30AM
Oct-21-24 07:00AM
Oct-10-24 07:00AM
Oct-09-24 12:34PM
Sep-27-24 05:45AM
Sep-23-24 07:00AM
Sep-13-24 05:45AM
Aug-30-24 10:22AM
Aug-15-24 05:52PM
06:09AM
Loading…
Aug-07-24 06:09AM
(Thomson Reuters StreetEvents)
Aug-06-24 08:15AM
07:17AM
(Associated Press Finance)
07:03AM
Jul-17-24 07:00AM
Jul-16-24 07:00AM
Jul-10-24 12:13PM
06:32AM
Jul-09-24 07:00AM
07:00AM
Jun-24-24 07:00AM
03:11AM
Jun-18-24 07:00AM
Jun-11-24 07:00AM
May-23-24 07:00AM
07:15AM
Loading…
May-16-24 07:15AM
May-13-24 11:18AM
May-09-24 07:00AM
May-08-24 01:03PM
07:43AM
03:16AM
May-07-24 10:38PM
(Thomson Reuters StreetEvents)
01:53PM
09:34AM
08:21AM
(Associated Press Finance)
08:00AM
Apr-26-24 06:37AM
Apr-23-24 07:00AM
Apr-16-24 07:00AM
Mar-18-24 07:00AM
Mar-12-24 11:01AM
Mar-07-24 01:40PM
09:53AM
Mar-06-24 08:21AM
(Thomson Reuters StreetEvents) +8.69%
Mar-05-24 10:52PM
04:42PM
(Associated Press Finance)
04:03PM
Feb-29-24 07:00AM
Feb-21-24 07:00AM
Jan-18-24 07:00AM
Jan-16-24 07:00AM
Jan-09-24 08:00AM
Jan-08-24 07:00AM
Dec-27-23 08:45AM
Dec-21-23 07:00AM
Dec-12-23 07:00AM
Dec-11-23 09:55AM
Dec-01-23 06:16PM
Nov-29-23 12:21PM
07:00AM
Nov-28-23 11:30AM
07:00AM
Nov-27-23 10:48AM
Nov-24-23 12:28PM
Nov-23-23 09:55AM
Nov-21-23 06:30PM
Nov-13-23 09:00AM
Nov-09-23 01:43PM
Nov-08-23 05:36PM
(Associated Press Finance)
04:07PM
09:00AM
Nov-07-23 03:59PM
Nov-06-23 07:00AM
Nov-02-23 10:00AM
Nov-01-23 10:01AM
Oct-31-23 01:48PM
Oct-29-23 09:00PM
Oct-23-23 09:00PM
03:54PM
Oct-18-23 09:00PM
07:00AM
Oct-17-23 08:33AM
Oct-13-23 09:00PM
08:40PM
08:23AM
Oct-12-23 09:10AM
07:00AM
Oct-09-23 05:25PM
01:48PM
Oct-08-23 09:00PM
Oct-06-23 09:13AM
Oct-02-23 09:00PM
Sep-27-23 09:00PM
Sep-21-23 09:22AM
Sep-20-23 07:00AM
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kenny Kevin J. President of Global Spine Jan 08 '24 Option Exercise 0.00 5,959 0 147,321 Jan 10 04:55 PM
Index -
P/E -
EPS (ttm) -2.77
Insider Own 8.24%
Shs Outstand 50.32M
Perf Week 25.74%
Market Cap 39.83M
Forward P/E -
EPS next Y -1.42
Insider Trans -1.94%
Shs Float 48.21M
Perf Month 25.84%
Income -140.94M
PEG -
EPS next Q -0.42
Inst Own 91.22%
Short Float 7.20%
Perf Quarter -12.85%
Sales 114.73M
P/S 0.35
EPS this Y 28.15%
Inst Trans -21.30%
Short Ratio 1.79
Perf Half Y -75.02%
Book/sh 0.91
P/B 0.84
EPS next Y 27.06%
ROA -46.94%
Short Interest 3.47M
Perf Year -79.21%
Cash/sh 3.38
P/C 0.23
EPS next 5Y 23.80%
ROE -141.02%
52W Range 0.44 - 6.37
Perf YTD -85.82%
Dividend Est. -
P/FCF -
EPS past 5Y -15.08%
ROI -56.79%
52W High -87.96%
Beta 2.05
Dividend TTM -
Quick Ratio 5.04
Sales past 5Y 202.67%
Gross Margin 30.97%
52W Low 76.32%
ATR (14) 0.08
Dividend Ex-Date -
Current Ratio 6.49
EPS Y/Y TTM 22.69%
Oper. Margin -112.32%
RSI (14) 66.73
Volatility 16.76% 9.24%
Employees 480
Debt/Eq 4.23
Sales Y/Y TTM -13.00%
Profit Margin -122.84%
Recom 2.25
Target Price 2.89
Option/Short Yes / Yes
LT Debt/Eq 4.19
EPS Q/Q 40.20%
Payout -
Rel Volume 0.79
Prev Close 0.78
Sales Surprise 6.81%
EPS Surprise 11.36%
Sales Q/Q -5.59%
Earnings Nov 06 AMC
Avg Volume 1.94M
Price 0.77
SMA20 27.77%
SMA50 33.02%
SMA200 -67.99%
Trades
Volume 1,529,728
Change -1.17%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-08-24 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$6 → $3
Jun-21-24 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$5 → $6
Apr-08-24 Initiated
BTIG Research
Buy
$6
Apr-05-24 Upgrade
CL King
Neutral → Buy
$6
Jan-12-24 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$14 → $6
Oct-13-23 Downgrade
BofA Securities
Buy → Underperform
$32 → $3
Aug-17-23 Initiated
CL King
Neutral
Nov-11-22 Initiated
RBC Capital Mkts
Outperform
$23
Jul-14-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$48 → $20
Mar-02-22 Resumed
BofA Securities
Buy
$50
Feb-17-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$50
Aug-18-21 Initiated
Cowen
Outperform
$70
Apr-19-21 Initiated
Wells Fargo
Overweight
$63
Dec-16-20 Initiated
Oppenheimer
Perform
Oct-12-20 Initiated
SVB Leerink
Mkt Perform
$60
Oct-12-20 Initiated
Stifel
Buy
$54
Oct-12-20 Initiated
Morgan Stanley
Equal-Weight
$48
Oct-12-20 Initiated
Goldman
Buy
$54
Oct-12-20 Initiated
BofA Securities
Buy
$54
Oct-12-20 Initiated
Barclays
Overweight
Show Previous Ratings
Nov-07-24 04:00PM
Nov-06-24 05:25PM
04:02PM
Nov-05-24 08:09AM
Oct-23-24 04:05PM
09:00AM
Loading…
09:00AM
Oct-18-24 04:25AM
Oct-16-24 06:56PM
Oct-14-24 01:27PM
Oct-11-24 06:45AM
Sep-27-24 08:26AM
Sep-23-24 03:57PM
Sep-20-24 09:13AM
Sep-17-24 05:45AM
Sep-13-24 05:45AM
01:23AM
Loading…
Sep-12-24 01:23AM
01:14AM
01:08AM
Sep-11-24 03:44PM
Sep-09-24 04:10PM
Sep-06-24 01:47PM
Sep-04-24 03:23PM
Sep-03-24 11:57AM
Aug-31-24 05:52PM
Aug-26-24 09:00PM
Aug-07-24 06:35PM
04:03PM
Jul-31-24 10:01AM
Jul-24-24 09:00AM
Jul-01-24 06:00AM
12:00PM
Loading…
Jun-10-24 12:00PM
Jun-03-24 04:05PM
May-13-24 06:59AM
May-10-24 03:48PM
May-09-24 03:44PM
09:42AM
(Thomson Reuters StreetEvents)
03:57AM
May-08-24 08:58PM
05:45PM
04:02PM
May-06-24 08:48AM
08:00AM
May-03-24 09:43AM
May-01-24 04:30PM
(Business Wire) +12.65%
+5.26%
Apr-19-24 08:30AM
Apr-18-24 01:36PM
Apr-17-24 08:30AM
Apr-15-24 08:30AM
Mar-13-24 04:02PM
Mar-05-24 03:34PM
(The Wall Street Journal)
Feb-26-24 09:00AM
Feb-22-24 10:51AM
07:10AM
(Thomson Reuters StreetEvents)
Feb-21-24 04:49PM
04:05PM
Feb-20-24 04:25PM
Feb-05-24 10:00AM
08:30AM
Jan-08-24 08:30AM
Jan-03-24 08:30AM
Nov-29-23 04:05PM
Nov-25-23 11:43AM
Nov-23-23 06:30AM
Nov-16-23 02:46PM
Nov-09-23 04:05PM
Nov-07-23 04:31PM
04:05PM
Nov-02-23 10:00AM
09:35AM
Nov-01-23 09:00AM
Oct-31-23 02:00PM
10:01AM
Oct-30-23 04:05PM
Oct-27-23 11:42AM
Oct-19-23 12:31PM
Oct-17-23 05:36PM
09:35AM
Oct-16-23 08:14AM
Oct-13-23 07:21PM
09:50AM
Oct-12-23 04:05PM
Aug-29-23 04:05PM
Aug-14-23 09:24PM
Aug-02-23 05:55PM
04:05PM
Jul-13-23 08:30AM
Jul-10-23 01:09PM
10:48AM
Jun-15-23 06:56AM
Jun-06-23 04:05PM
May-30-23 07:30AM
May-05-23 06:14AM
May-04-23 09:13AM
(Thomson Reuters StreetEvents)
May-03-23 06:35PM
04:05PM
Apr-30-23 05:50AM
Apr-25-23 08:30AM
Apr-23-23 07:03AM
Apr-12-23 09:05AM
08:30AM
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Trigg Leslie Chair and CEO Aug 15 '24 Sale 0.84 5,308 4,459 910,496 Aug 15 08:02 PM Nash Marc SVP Operations and R&D Aug 15 '24 Sale 0.84 1,293 1,086 239,397 Aug 15 08:01 PM Brottem John L. General Counsel Aug 15 '24 Sale 0.84 3,011 2,529 230,295 Aug 15 07:59 PM Ahmed Nabeel Chief Financial Officer Aug 15 '24 Sale 0.84 3,971 3,336 314,988 Aug 15 07:57 PM Trigg Leslie Officer Aug 15 '24 Proposed Sale 0.84 5,308 4,459 Aug 15 06:49 PM Nash Marc Officer Aug 15 '24 Proposed Sale 0.84 1,293 1,086 Aug 15 06:49 PM Brottem John L. Officer Aug 15 '24 Proposed Sale 0.84 3,011 2,529 Aug 15 06:47 PM Ahmed Nabeel Officer Aug 15 '24 Proposed Sale 0.84 3,971 3,336 Aug 15 06:46 PM Nash Marc SVP Operations and R&D Jul 24 '24 Sale 4.02 723 2,906 240,690 Jul 24 07:08 PM Brottem John L. General Counsel Jun 12 '24 Sale 4.78 10,569 50,520 233,306 Jun 14 04:17 PM GROSSMAN D KEITH Director Jun 03 '24 Option Exercise 1.11 69,303 76,926 85,922 Jun 03 06:57 PM GROSSMAN D KEITH Director Jun 03 '24 Sale 3.78 38,117 144,234 47,805 Jun 03 06:57 PM Ahmed Nabeel Chief Financial Officer May 16 '24 Sale 3.53 3,918 13,831 318,959 May 17 05:40 PM Nash Marc SVP Operations and R&D May 16 '24 Sale 3.53 1,097 3,872 241,413 May 17 05:38 PM Brottem John L. General Counsel May 16 '24 Sale 3.53 2,972 10,491 243,875 May 17 05:36 PM Trigg Leslie Chair and CEO May 16 '24 Sale 3.53 5,237 18,487 915,804 May 17 05:25 PM Racine Jean-Olivier Chief Technology Officer May 10 '24 Sale 3.27 8,306 27,161 265,325 May 10 06:19 PM Nash Marc SVP Operations and R&D Mar 15 '24 Sale 2.13 2,391 5,093 242,510 Mar 15 06:40 PM Ahmed Nabeel Chief Financial Officer Mar 01 '24 Sale 3.15 1,584 4,990 322,877 Mar 04 04:34 PM Williamson Steven S. Chief Commercial Officer Feb 15 '24 Sale 3.57 2,500 8,925 320,347 Feb 16 05:31 PM Trigg Leslie Chair and CEO Feb 15 '24 Sale 3.57 5,320 18,992 833,091 Feb 16 05:29 PM Racine Jean-Olivier Chief Technology Officer Feb 15 '24 Sale 3.57 1,866 6,662 271,830 Feb 16 05:28 PM Nash Marc SVP Operations and R&D Feb 15 '24 Sale 3.57 617 2,203 243,100 Feb 16 05:27 PM Brottem John L. General Counsel Feb 15 '24 Sale 3.57 3,341 11,927 245,046 Feb 16 05:26 PM Ahmed Nabeel Chief Financial Officer Feb 15 '24 Sale 3.57 4,403 15,719 312,594 Feb 16 05:24 PM Williamson Steven S. Chief Commercial Officer Jan 16 '24 Sale 4.29 996 4,273 322,847 Jan 17 08:04 PM Trigg Leslie Chair and CEO Jan 16 '24 Sale 4.29 8,126 34,861 838,411 Jan 17 08:03 PM Racine Jean-Olivier Chief Technology Officer Jan 16 '24 Sale 4.29 723 3,102 273,696 Jan 17 08:03 PM Porter Stacey L. Chief People Officer Jan 16 '24 Sale 4.29 768 3,295 61,448 Jan 17 08:02 PM Nash Marc SVP Operations and R&D Jan 16 '24 Sale 429.00 678 290,862 243,717 Jan 17 08:01 PM Brottem John L. General Counsel Jan 16 '24 Sale 4.29 1,480 6,349 248,387 Jan 17 08:00 PM Ahmed Nabeel Chief Financial Officer Jan 16 '24 Sale 4.29 1,726 7,405 316,997 Jan 17 07:59 PM Williamson Steven S. Chief Commercial Officer Jan 08 '24 Sale 5.49 7,055 38,732 105,939 Jan 08 08:35 PM Trigg Leslie Chair and CEO Jan 08 '24 Sale 5.49 14,188 77,892 389,099 Jan 08 08:34 PM Racine Jean-Olivier Chief Technology Officer Jan 08 '24 Sale 5.49 3,905 21,438 73,781 Jan 08 08:33 PM Porter Stacey L. Chief People Officer Jan 08 '24 Sale 5.49 4,766 26,165 58,630 Jan 08 08:31 PM Brottem John L. General Counsel Jan 08 '24 Sale 5.49 7,344 40,319 48,807 Jan 08 08:30 PM Ahmed Nabeel Chief Financial Officer Jan 08 '24 Sale 5.49 10,709 58,792 76,819 Jan 08 08:29 PM Williamson Steven S. Chief Commercial Officer Nov 16 '23 Sale 4.76 3,584 17,060 112,994 Nov 17 04:22 PM Trigg Leslie Chair and CEO Nov 16 '23 Sale 4.76 3,175 15,113 403,287 Nov 17 04:19 PM Racine Jean-Olivier Chief Technology Officer Nov 16 '23 Sale 4.76 790 3,760 77,686 Nov 17 04:18 PM Porter Stacey L. Chief People Officer Nov 16 '23 Sale 4.76 671 3,194 63,396 Nov 17 04:17 PM Nash Marc SVP Operations and R&D Nov 16 '23 Sale 4.76 562 2,675 44,757 Nov 17 04:15 PM Brottem John L. General Counsel Nov 16 '23 Sale 4.76 1,431 6,812 56,151 Nov 17 04:15 PM Ahmed Nabeel Chief Financial Officer Nov 16 '23 Sale 4.76 1,643 7,821 87,528 Nov 17 04:08 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite